- Home
- BGLC vs AMST Comparison
BGLC vs AMST Comparison
Compare BGLC & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- AMST
- Stock Information
- Founded
- BGLC 2017
- AMST 2017
- Country
- BGLC Malaysia
- AMST United States
- Employees
- BGLC N/A
- AMST N/A
- Industry
- BGLC Medical Specialities
- AMST Computer Software: Prepackaged Software
- Sector
- BGLC Health Care
- AMST Technology
- Exchange
- BGLC Nasdaq
- AMST Nasdaq
- Market Cap
- BGLC 7.6M
- AMST 7.4M
- IPO Year
- BGLC N/A
- AMST 2020
- Fundamental
- Price
- BGLC $0.30
- AMST $2.35
- Analyst Decision
- BGLC
- AMST
- Analyst Count
- BGLC 0
- AMST 0
- Target Price
- BGLC N/A
- AMST N/A
- AVG Volume (30 Days)
- BGLC 78.2K
- AMST 19.9K
- Earning Date
- BGLC 11-20-2024
- AMST 11-26-2024
- Dividend Yield
- BGLC N/A
- AMST N/A
- EPS Growth
- BGLC N/A
- AMST N/A
- EPS
- BGLC N/A
- AMST N/A
- Revenue
- BGLC $9,183,168.00
- AMST $166,881.00
- Revenue This Year
- BGLC N/A
- AMST N/A
- Revenue Next Year
- BGLC N/A
- AMST N/A
- P/E Ratio
- BGLC N/A
- AMST N/A
- Revenue Growth
- BGLC N/A
- AMST N/A
- 52 Week Low
- BGLC $0.31
- AMST $1.72
- 52 Week High
- BGLC $3.39
- AMST $4.34
- Technical
- Relative Strength Index (RSI)
- BGLC 28.91
- AMST 42.19
- Support Level
- BGLC $0.32
- AMST $2.31
- Resistance Level
- BGLC $0.38
- AMST $3.00
- Average True Range (ATR)
- BGLC 0.02
- AMST 0.18
- MACD
- BGLC -0.00
- AMST -0.04
- Stochastic Oscillator
- BGLC 0.00
- AMST 21.74
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.